SMAD2 and ovarian carcinoma: In particular, we examined the ability of UCHL5 to de-ubiquitinate and stabilize Smad2/Smad3 in ovarian cancer cell lines, thereby promoting TGF-β signaling and contributing to the pathogenesis of TP53-mutant ovarian cancer.